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Aggregation of R-synuclein (R-syn), a protein implicated in Parkinson’s disease (PD), is believed to progress
through formation of a partially folded intermediate. Using nanoelectrospray ionization (nano-ESI) mass
spectrometry combined with ion mobility measurements we found evidence for a highly compact partially
folded family of structures for R-syn and its disease-related A53T mutant with net charges of -6, -7, and
-8. For the other early onset PD mutant, A30P, this highly compact population was only evident when the
protein had a net charge of -6. When bound to spermine near physiologic pH, all three proteins underwent
a charge reduction from the favored solution charge state of -10 to a net charge of -6. This charge reduction
is accompanied by a dramatic size reduction of about a factor of 2 (cross section of 2600 Å2 (-10 charge
state) down to 1430 Å2 (-6 charge state)). We conclude that spermine increases the aggregation rate of
R-syn by inducing a collapsed conformation, which then proceeds to form aggregates.
Introduction
R-Synuclein (R-syn) is the primary proteinaceous material
implicated in the pathogenesis of Parkinson’s disease (PD).
Although the etiology of PD is still unknown, R-syn became
the focus of PD research when it was first discovered as the
primary fibrillar component in Lewy bodies and Lewy neurites
found in the brains of PD patients.1 Additionally, rare inherited
autosomal early onset forms of PD are linked to two missense
mutations, A53T and A30P, found in the gene that codes for
R-syn.2,3 In recent years, a growing body of evidence suggests
that oligomeric assemblies of R-syn are responsible for the toxic
effects seen in PD and that the fibrillar deposits are perhaps a
byproduct of neuronal death.4–6
R-Syn belongs to a family of closely related presynaptic
proteins. It is highly soluble and has 140 amino acid residues
including 7 imperfect repeats near the N-terminal region and a
highly acidic C-terminal region. In vitro studies of R-syn and
the A30P and A53T mutants show the proteins are natively
unfolded, having little or no ordered structure in the soluble
form under physiologic conditions.7–9 Small-angle X-ray scat-
tering studies indicate that at neutral pH these proteins have
radii of gyration of about 40 Å, larger than expected for a folded
globular protein (15 Å) and smaller than predicted for a random
coil conformation (52 Å).7,10 Fibrillization is believed to be a
byproduct of R-syn misfolding that occurs in a nucleation-
dependent mechanism4 initiated by a critical structural trans-
formation from an unfolded conformation to a partially folded
intermediate.7 These studies indicate that R-syn most likely
populates several intermediate conformations, both monomeric
and oligomeric, on the pathway to the mature fibril form.7,11
The rate of aggregation is affected by both the A53T and A30P
mutations. It is generally agreed upon that the A53T mutation
increases the rate of aggregation,4,11–14 but studies on the A30P
mutation have been far less conclusive. There are reports of
faster aggregation,13 similar aggregation rates,14 and more rapid
monomer consumption but slower fibril formation relative to
WT R-syn.4,11,12
Spermine is a naturally occurring polyamine found in
neuronal cells15–17 that has, along with other polyamines, been
shown to increase the rate of aggregation and fibrillization of
R-syn.18,19 Although a complete profile of its functions is still
unknown, spermine is known to be involved in neurodegen-
erative processes.20 At physiologic pH, spermine exists as a
polycation and forms a complex with R-syn. This complex
formation increases the rate of R-syn fibrillization without
inducing significant secondary structure in this natively unfolded
protein.18,19,21 A recent NMR study demonstrated that although
spermine is known to bind in the highly acidic C-terminal
region, the complex 1H-15N HSQC spectrum shows significant
intensity changes in the peaks corresponding to glycine and
threonine residues in the N-terminal region, amino acids 22-93,
as compared to the free protein.21 The two mutants investigated
in this study, A30P and A53T, have substitutions in this region,
and we were curious to see if these substitutions had a significant
effect on the complex structures.
It is critical to pursue methods that give insight into the actual
structure of the R-syn monomers and probe any structural
transitions that may occur in order to develop effective
therapeutic strategies. Ion mobility spectroscopy is a powerful
method for achieving this goal, allowing accurate measurement
of collision cross sections (shape). In this study we used ion
mobility combined with mass spectrometry to examine the
structural features of the A30P and A53T mutant monomers
and spermine complexes in comparison to WT R-syn.
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Materials and Methods
Sample Preparation. Spermine was purchased from Sigma
(St. Louis, MO) and used without further purification. All R-syn
samples were purchased from rPeptide (Bogart, GA). Samples
for nano-ESI experiments were prepared by dissolving the
lyophilized proteins in water to make concentrated stock
solutions. pH 7.5 and 2.5 solutions were prepared by dialyzing
the stock solutions in 10 mM ammonium acetate overnight using
Slide-a-lyzer Mini Dialysis Units (3.5K MWCO, Pierce Bio-
technology, Rockford, IL). Samples were then filtered using
Microcon YM-100 Centrifugal Filter Devices (100K MWCO,
Millipore Corp., Billerica, MA) to filter out large aggregates
and adjusted to the desired pH using NH4OH and CH3COOH.
The concentrations were determined from UV absorption using
an estimated extinction coefficient of 5120 M-1 cm-1 at 280
nm.22 Solutions were diluted to ∼5-10 µM concentrations
immediately prior to use. For samples containing spermine,
spermine was added after this final dilution in a 1:10 R-syn to
spermine ratio. Samples were left in a refrigerator overnight,
to improve binding, before running.
Instrumentation. Details of the experimental set up for
obtaining mass spectra and ion mobilities have previously been
published elsewhere,23 so only a brief description will be given
here. The instrument consists of a nanoelectrospray ionization
(nano-ESI) source, an ion funnel, a drift cell, and a quadrupole
mass filter. Ions are generated in the source from ∼5 µL of
sample solution contained in a metal-coated borosilicate capil-
lary (Proxeon, Odense, Denmark). A continuous beam of ions
is created and injected into the ion funnel. The ion funnel acts
as an interface between the source and high-vacuum chamber
and transports the ions to the drift cell without the use of high-
acceleration fields. The drift cell is filled with∼5 Torr of helium
buffer gas and followed by a quadrupole mass filter and detector.
To obtain mass spectra a continuous beam of ions passes through
the drift cell and quadrupole mass filter before arriving at the
detector.
To obtain mobility data the ion funnel is used as a storage
device and the ions are pulsed into the drift cell triggering a
timing sequence. Once the ions enter the cell, they are quickly
thermalized by collisions with the helium buffer gas and pulled
through the drift cell by a weak electric field, E. Due to the
counterbalance of the forward acceleration and the frictional
drag, the ions obtain a constant drift velocity, VD, proportional
to E
VD )KE (1)
where the proportionality constant K is the ion mobility. In the
low-field limit, K is a function of the buffer gas pressure, P,
temperature, T, reduced mass, µ, of the colliding particles (ion
+ He), and ion’s collision cross section, σ.
Once the ions exit the drift cell, they pass through the
quadrupole mass filter and are detected as a function of time,
producing an arrival time distribution (ATD). Through the use
of kinetic theory, the mobility is related to the collision cross
section, σ, as given in eq 224
σ) 1.3( z2E2TµkBP2N2l2)0.5(tA - t0) (2)
where z is the charge on the ion, kB is the Boltzmann constant,
N is the He number density at STP, l is the length of the cell,
tA is the time it takes the ion to arrive at the detector after the
initial pulse into the drift cell, and t0 is the time it takes the
ions to reach the detector after exiting the drift cell. Since all
of the constants in eq 2 are known for a given experiment and
P, T, E, and tA, and t0 can be very accurately measured, a precise
value of σ is obtained.
The injection energy with which ions enter the drift cell is
an important variable. At low injection energies the ions are
gently pushed into the cell and only need a few “cooling”
collisions to reach thermal equilibrium with the buffer gas. At
high injection energies the larger collision energy leads to
internal excitation of the ions before cooling and equilibrium
occur. This can lead to isomerization to the most stable gas-
phase conformations or dissociation of dimers and higher order
oligomers if they are present. Unless otherwise stated, all mass
spectra and ATDs were taken at an intermediate injection energy
value of 40-50 eV.
Results
Negative-ion mass spectra were collected at pH 2.5 and 7.5
for WT R-syn and its A30P and A53T mutants. Negative-ion
mode was chosen due to the large number of acidic residues, D
and E, relative to basic residues, K and R, in the amino acid
sequence of the proteins (24 compared to 15), resulting in a
net negative charge in solution at neutral pH. As all three
proteins produced very similar mass spectra, only the A30P
mutant spectra are presented in Figure 1. The negative-ion mass
spectrum of the A30P mutant at pH 7.5 shows a broad
distribution of charge states ranging from -6 to -17, centered
at -13. There is also a second smaller distribution of half-integer
charge states (i.e., z/n ) -15/2, -17/2..., where z is the ion
charge and n is the oligomer order). At pH 2.5 the charge-state
distribution is shifted to lower charge states, centered at -9,
significantly narrowed, ranging only from -6 to -11, and the
half-integer charge states no longer appear. This shift in charge-
state distribution is consistent with a protein that is natively
unfolded at pH 7.5 and partially folded at pH 2.5.25–28 In
addition, the smaller aggregates appear to have further ag-
gregated to larger oligomers out of the mass range of our
quadrupole. These same trends are observed for the A53T
mutant as well as WT R-syn.29
Arrival time distributions (ATDs) were obtained and cross
sections measured for charge states -6 and above for each
sample. For charge states that were present at both pH 2.5 and
7.5, ATDs and cross sections are comparable at each pH, the
Figure 1. Negative-ion mass spectrum of A30P R-syn shows a broad
distribution at pH 7.5 which is shifted to lower charge states and
significantly narrowed at pH 2.5.
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one exception being the -10 charge state for the two mutants.
The A30P mutant -10 ATD contains a single peak at pH 2.5
but has two features at pH 7.5, while the A53T mutant -10
ATD contains two features at pH 2.5 and only a single peak at
pH 7.5. It is important to note however that the overall peak
width and average cross section of this charge state for both
mutants is the same at each pH. In addition, multiple features
are present in the ATDs for the low charge states -6 through
-8 for WT R-syn and the A53T mutant and -6 through -9
for the A30P mutant.
The mass spectrum at pH 7.5 in Figure 1 contains a charge-
state distribution composed of half-integer charge states which
arises from the presence of multiply charged oligomers.
Therefore, a percentage of each monomer peak in the mass
spectrum may be composed of multiply charged oligomer (a
monomer with 7 charges and a dimer with 14 charges have the
same z/n value) which may contribute to the ATD for that charge
state. However, data was taken under a variety of solution
conditions (data not shown), some of which led to mass spectra
in which no evidence for multiply charged oligomers was
present. In all cases, the overall ATD peak width for a particular
whole number charge state and the structures in the ATD are
conserved, i.e., the ATDs for the -6 charge state look essentially
the same regardless of how much multiply charged oligomer is
observable in the mass spectrum. Since the ATDs for samples
where oligomers were present in the mass spectrum appear
qualitatively the same as ATDs for samples with no multiply
charged oligomers present in the mass spectrum, it appears that
we are primarily observing the ATDs for monomeric forms of
the protein for whole integer z/n peaks. The ATDs presented in
Figures 2 and 3 were taken at pH 2.5, where no dimer peaks
are observed under any source conditions, so these are unam-
biguously pure monomer ATDs.
For each of the ATDs exhibiting multiple features, the
dominant feature varies with injection energy, as shown in
Figure 2 for the WT R-syn -7 ATD at pH 2.5. At low injection
energy (30 eV), the ATD has a broad distribution centered near
870 µs. The broadness of the distribution implies that there are
several conformers present, and there is a dominant family of
structures with an average cross section of 1730 Å2. When the
injection energy is increased (50 eV), the ATD is shifted toward
later arrival times. At high injection energy (100 eV), a dominant
family of structures is seen again, this time with an average
cross section of 2078 Å2. These results suggest the more
compact structures are present in solution, and we observe these
at low injection energies, but as the injection energy is increased
they are annealed to a family of more extended structures
preferred in the solvent-free state.
At higher charge states the ATDs all become much narrower
and contain a single feature. Figure 3 shows a comparison of
ATDs taken at pH 2.5 for several charge states of WT R-syn
and both the A30P and A53T mutants. ATDs for WT R-syn
and the A53T mutant at each charge state are very similar. For
the -7 and -8 charge states, ATDs for WT R-syn and the A53T
mutant are much broader than the corresponding ATDs for the
A30P mutant. For these charge states the A30P mutant populates
more extended families of structures than WT R-syn and the
A53T mutant. ATDs for the -9 charge state for each protein
have similar widths, although the A30P mutant ATD has
multiple features. However, the broadness of the WT R-syn and
A53T mutant ATDs could easily contain multiple unresolved
features. After the -9 charge state, all three proteins have
significantly narrowed distributions, and for charge states -11
and above they all contain a single well-defined peak as
exemplified by the -12 charge state.
Cross sections measured for the monomer charge states of
all three samples are summarized in Figure 4. Since pH does
not appear to affect the cross sections, average cross sections
across both pHs are plotted. There is a family of relatively
compact structures dominant in low charge states and one of
more extended structures dominant in high charge states. For
WT R-syn and the A53T mutant the compact family of
structures is present in charge states -6 through -8. For the
A30P mutant however, this compact family is seen only in the
-6 charge state. The extended family of structures in all three
proteins increases in cross section with charge state due to
Coulomb repulsion between the charges, leading to more open
structures and larger cross sections as z/n increases.
When spermine was added to the protein solutions a stable
spray could not be obtained from acidic solutions, but good
data were obtained from neutral solutions. A mass spectrum of
the pure A53T mutant is given in Figure 5a for reference. As
shown in Figure 5b, at an intermediate injection energy of 50ev,
when spermine is added a bimodal distribution of charge states
is observed with -9 being locally dominant but -6 clearly being
the dominant charge state overall. This represents a huge shift
in the dominant charge state, which ranges from -11 through
-13 for the neutral solutions without spermine, where the -6
peak is barely visible. Satellite peaks are clearly visible at higher
mass, representing R-syn/spermine complexes, and the dimer
peaks evident at half-integral z/n values in Figure 5a have
disappeared, most likely due to increased oligomerization. One
very interesting thing about this spectrum is that not only is the
[R-syn + spermine]-6 peak the largest of the complex peaks,
but [R-syn]-6 is the largest unbound charge state as well. At a
high injection energy of 100 eV, Figure 5c, the R-syn/spermine
complex peaks are no longer observed and large unresolved
peaks from dissociation of higher order oligomers are present.
In addition, highly charged monomers are observed that are only
Figure 2. ATD for the -7 charge state of WT R-syn at pH 2.5
demonstrates how the dominant features of low charge state ATDs vary
with injection energy.
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weakly present in Figure 5b, presumably from monomer
dissociation from the large oligomers.30,31
ATDs for the -6 charge state of the A53T mutant from
solutions both with and without spermine at an injection energy
of 50 eV are given in Figure 6. All three ATDs are complex
with families of conformations having cross sections near 1440
and 1780 Å2. The relative intensities of the peaks in the ATDs
of the free protein in solution and the unbound protein in the
complex solution are very similar, while the peak corresponding
to the more compact conformational family dominates the ATD
of the R -syn/spermine complex. Of interest is the fact that no
new conformational families were observed, only a strong shift
to more compact structures. WT R-syn and the A30P mutant
gave similar results. It is also important to notice that no dimers
are present in the mass spectrum in Figure 5b that yielded the
ATDs in Figure 6b and 6c. Hence, these ATDs are due to pure
monomer. The ATD in Figure 6a is very similar to the one in
Figure 6b, strongly supporting the fact it is also due to monomer.
Discussion
As shown in Figure 1 the A30P mutant has a much narrower
and lower charge-state distribution at pH 2.5 than at pH 7.5.
This same behavior is observed for the A53T mutant and WT
R-syn29 as well. The shift in charge-state distribution alone is
evidence that the protein is more compact under acidic compared
to physiologic conditions,25–28 but further evidence comes from
looking beyond charge-state distribution and comparing the cross
sections of each charge state. Since low-charge states have
smaller cross sections and more of the protein exists in low
charge states at pH 2.5 than at pH 7.5, this implies that the
protein is more compact at the lower pH. A number of factors
are known to trigger aggregation in WT R-syn by inducing a
partially folded state, including low pH.7
ATDs for WT R-syn and the A53T mutant show evidence
of a highly compact, partially folded family of structures for
net charges -6, -7, and -8. The A30P mutant ATDs however
only demonstrate this partially folded state at a net charge of
-6. As can be seen in Figure 4 the cross sections of the more
extended families of structures for the -7 and -8 charge states
are very similar for all three proteins, but the smallest structures
observed for the A30P mutant are 30-40% larger than the
smallest structures observed for WT R-syn and the A53T mutant.
Fluorescence energy-transfer (FET) kinetics experiments by Lee
et al.32 have shown that the distances between two donor/
acceptor pairs in the vicinity of residue 30 were increased for
the A30P mutant relative to WT R-syn in neutral solutions, while
in acidic solutions the distances decreased. Since our results
show an increase in cross section at both neutral and acidic
pHs, the mutation must be inducing a large-scale structural
change in the protein that outweighs this localized compaction
in acidic conditions. The single-residue mutation, substitution
of a proline in place of an alanine, causes a significant increase
Figure 3. ATDs of several charge states taken at an injection energy of 50 eV at pH 2.5. For charge states -7 and -8 the A30P mutant ATDs
are much narrower than the WT and A53T mutant ATDs.
Figure 4. Cross section vs charge state for WT R-syn and its A53T
and A30P mutants. Two families of structures are clearly evident, one
dominant in low charge states and one dominant in high charge states.
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in the overall size of the compact structures of R-syn and most
likely prevents formation of the partially folded intermediate
with a net charge of more than -6. This dramatic dependence
of foldedness on charge may account for some of the incon-
clusive results on aggregation rates of the A30P mutant
compared to WT R-syn.4,11–14 The A30P mutation is known to
disrupt a region of residual helical structure found near the
N-terminus in the WT protein,33 and this may be a contributing
factor for the increase in cross sections that we observe.
Another factor known to increase R-syn aggregation is
binding with cationic species such as metal ions34–38 and
polyamines.18,19,21 Interestingly, while metal-ion binding is
thought to increase aggregation by facilitating collapse into a
partially folded state,37 binding of polyamines appears to trigger
aggregation without inducing significant changes in secondary
structure.18,19,21 One of the most effective polyamines in this
respect is spermine, a naturally occurring polyamine that binds
to R-syn via a specific interaction with the C-terminus and
increases the kinetic efficiency of aggregation by 105.21 Recent
NMR studies have shown that although spermine binds near
the C-terminus, structural changes may occur near the N-
terminus, particularly affecting glycine and threonine residues
in the region aa22-93.21,39 In spite of this interaction, data
collected for the A53T mutant, which introduces a threonine
residue in the aa22-93 region, were the same as that for WT
R-syn and the A30P mutant.
Addition of spermine to all three protein samples results in
a dominant charge state of -6 in each mass spectrum. In
solution at pH 7.5, the protein exists in an equilibrium of
conformations, but being natively unfolded at this pH, the
majority of R-syn is expected to have a net charge between -9
and -10. A plot of net charge on R-syn vs pH, as estimated
from the protein sequence and amino acid pKa values,40 is given
in Figure 7. At pH 7.5 spermine, shown schematically in Figure
5b, exists as a polycation with net charge +4, so it is reasonable
to predict that in solution the net charge of the protein/cation
complex is -6. The dominance of the -6 charge state in the
mass spectrum of the R -syn/spermine mixture (Figure 5b) and
presence of a bimodal charge-state distribution, rather than a
shift of the original charge-state distribution by four charges,
shows that spermine forms a compact folded complex with
R-syn in solution, reducing the number of sites available for
deprotonation during electrospray. Looking at the ATDs for this
charge state, we do not see any new conformational families
but do see a significant shift in intensity to favor the more
compact structures in the complex as compared to the unbound
protein. However, it is important to recall that spermine is
binding to a protein with a net charge of -10 in solution
(average cross section near 2600 Å2), reducing the charge to
-6 and reducing the cross section of most of the protein to
1430 Å2, a size reduction of nearly a factor of 2. Some very
small fraction of uncomplexed R-syn exists in the -6 charge
state in pure R-syn solutions under physiologic conditions, and
a fraction of that small fraction is in the compact conformation.
However, when spermine is added R-syn/spermine complexation
results, yielding nearly 100% compact R-syn.
The fact that not only is the -6 charge state dominant in the
R-syn/spermine complex charge-state distribution but also in
the free R-syn protein distribution strongly suggests that in
solution an [R-syn + spermine]-6 complex is dominantly
formed, which then partially dissociates to form [R-syn]-6 and
neutral spermine upon being sprayed, dehydrated, and traversing
the IMS-MS instrument. Since the [R-syn]-6 ATD in the R-syn/
spermine mixture closely resembles the ATD from the pure
R-syn sample, some refolding/unfolding must occur upon
spermine dissociation. The 1430 Å2 structure is most likely a
“solution” structure, while the 1780 Å2 structure is a “solvent-
free” structure which results from unfolding once spermine
dissociates. This process is shown schematically in Figure 8.
(This interpretation is also consistent with the 1730 Å2 structure
for [R-syn]-7 unfolding to a “solvent-free” structure at 2078
Å2 as injection energy is increased (Figure 2).) Exactly where
the dissociation of the R-syn/spermine complex occurs is not
apparent, but the lower intensity of the complex peak compared
to the unbound protein peak implies that it does occur
somewhere since it has previously been shown41 that a
significant amount of spermine-bound protein can be detected
by ESI-MS. Our instrumentation23 is very different from most
commercial mass spectrometers in that it incorporates an ion
funnel to capture, desolvate, and transport the ions coming out
of the capillary and a drift cell filled with ∼5 Torr of helium
buffer gas. A significant amount of energy must be imparted to
the ions in order to inject them from vacuum into the drift cell,
and this step may account for dissociation of the complex. In
fact, as injection energy is increased, the R-syn/spermine
complex is essentially completely dissociated (see Figure 5c).
Figure 5. Negative-ion mass spectrum of pure A53T R-syn taken at
pH 7.5 with an intermediate injection energy of 50 eV (a). Upon
addition of spermine under the same conditions (b) the charge-state
distribution is dramatically shifted and R-syn/spermine complex peaks
are observed. At a high injection energy of 100 eV (c), the complex
peaks are no longer easily observed and large unresolved peaks from
dissociation of higher order oligomers are present.
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It has been shown that the rate of fibrillization of R-syn in
vitro is significantly increased by the presence of certain metal
ions,34–38 most likely due to the metals’ ability to mask
electrostatic repulsions and facilitate collapse into a partially
folded intermediate.7,42 We propose that a similar process,
illustrated in Figure 9, takes place upon addition of spermine.
In the protein solution without spermine, a range of conforma-
tions exists in equilibrium, a small fraction of which are compact
while the majority are extended. Once spermine is added, most
of the extended conformations are rearranged to become more
compact due to the dramatic charge reduction. This R-syn/
spermine complex does not appear to result in any new
structures as the cross sections are very similar to the compact
form of the free -6 R-syn protein. We hypothesize that it is
these more compact conformations that aggregate and go on to
form fibrils. In the solution with no spermine, there are very
few of these compact conformations so aggregation will proceed
slowly. In the presence of spermine however, the higher
proportion of compact conformations induces faster aggregation,
possibly accounting for the 105 increase in aggregation ef-
ficiency.21
The mechanism of R-syn aggregation in the presence of
spermine is still not well understood, and models of the process
are varied. Electron capture dissociation41 (ECD) and NMR39
studies have proposed that spermine binding to R-syn leads to
larger, more extended structures. It has been suggested that
charge shielding resulting from spermine binding to the protein
reduces intramolecular electrostatic interactions between the
C-terminal region and central/N-terminal regions of R-syn,
reducing the protein’s overall compactness and forming an open
structure more favorable for self-assembly. It has also been
proposed19,43 that the increased rate of R-syn aggregation in the
presence of spermine can be accounted for by the binding of
spermine, causing a reduction in electrostatic repulsion between
molecules undergoing self-assembly. Alternatively, it has been
suggested that the multivalent polyamine may act as a bridge
between protein monomers.18,43 Like most natively unfolded
proteins, WT R-syn and its A30P and A53T mutants are
characterized by low hydrophobicity and high net charge.44
Several independent studies have shown that aggregation of
amyloidogenic proteins/peptides is very much dependent on net
charge with a lower net charge leading to faster aggregation.45–47
Reduction in net charge leading to a partially folded intermediate
has been proposed as the mechanism by which cationic metal
binding7,42 and low pH7 increase R-syn aggregation. In light of
the dramatic compaction spermine induces in R-syn as shown
here, it is reasonable to propose a similar effect from polyamines.
It is highly likely that protein aggregation is occurring in our
experiments, as evidenced by the significant overall loss of
Figure 6. ATDs of the A53T R-syn mutant showing the presence of similar conformational families in the free protein in solution (a), the unbound
protein in the complex solution (b), and the protein-spermine complex (c). A significantly greater percentage of the population is in the compact
form in the complex as compared to the unbound protein.
Figure 7. Plot of net charge on R-syn vs pH as estimated from its
amino acid composition.
Figure 8. Schematic representation of spermine binding to R-syn,
rearranging the protein, then dissociating as a neutral molecule.
Figure 9. Illustration of a hypothetical mechanism for the accelerated
aggregation of R-syn due to spermine binding.
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signal in the R-syn/spermine solutions relative to the pure R-syn
solutions (see enhanced noise level in Figure 5b and 5c relative
to Figure 5a). Dimer peaks evident in spectra from the pure
R-syn solutions (Figure 5a) are not present in spectra from
R-syn/spermine solutions (Figure 5b), presumably because they
have gone on to form higher order oligomers that are out of the
mass range of our instrument. Increasing the injection energy
causes some of the higher order oligomers to dissociate, creating
observable oligomers within our mass range. These oligomers
appear as large unresolved peaks in the mass spectrum shown
in Figure 5c.
It is important to consider how the solvent-free results
presented here relate to solution structures. As Loo48 pointed
out, there are several noncovalently bound protein ligand
complexes in which the observed gas-phase stoichiometry is in
agreement with that expected in the solution. There have also
been numerous studies in which elements of solution-phase
structure are preserved in the gas phase. Relevant examples
include, but are not limited to, large protein assemblies such as
GroEL-substrate complexes49 and the 11-membered ring com-
plex formed by the trp RNA binding attenuation protein
(TRAP),50 globular monomeric proteins including cytochrome
c,51 and smaller biomolecules such as the Alzheimer’s peptide
amyloid-beta.52 Our injection energy results indicate that at low
injection energies compact structures are observed while at
higher injection energies these tend to unfold, presumably to
more favorable solvent-free structures. Hence, we are confident
that the current results reflect solution properties of the system.
Conclusions
Highly compact families of structures are present for WT
R-syn and its A53T mutant with net charges of -6, -7, and
-8. The A30P mutant only exists in a highly compact form
with a net charge -6, possibly accounting for its inconsistent
aggregation behavior. All three proteins behave the same in the
presence of spermine. Spermine effectively binds to an extended
conformation and rearranges it to a much more compact form
by lowering the net charge from -10 to -6. Mass spectral
results suggest spermine complexation may induce oligomer-
ization of R-syn.
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